Ms. Hassan (for herself and Ms. Murkowski) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.
21 U.S.C. 802, 822, 823, 824
and
829a 25 U.S.C. 1616l 42 U.S.C. 1395cc-6, 1395l, 1395m, 1396b, 290bb-36d
and
290dd-3
Document Citations
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Mainstreaming Addiction Treatment Act of 2019. S. 2074. 116th
Cong., 1st
sess., Introduced in Senate July 10, 2019. https://www.govinfo.gov/app/details/BILLS-116s2074is.
APA
Congress, Senate (2019, July 10). Mainstreaming Addiction Treatment Act of 2019 (S. 2074 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-116s2074is.
MLA
United States, Congress, Senate. Mainstreaming Addiction Treatment Act of 2019. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-116s2074is. 116th Congress, S. 2074, Introduced in Senate 10 Jul. 2019.
Bluebook
S.2074 - 116th Congress (2019-2020): Mainstreaming Addiction Treatment Act of 2019, S.2074, 116th Cong. (2019), https://www.govinfo.gov/app/details/BILLS-116s2074is.
